Heal D J, Prow M R, Buckett W R
Boots Pharmaceuticals Research Department, Nottingham, UK.
Psychopharmacology (Berl). 1991;103(2):251-7. doi: 10.1007/BF02244212.
Clonidine (0.1 mg/kg IP)-induced hypoactivity and mydriasis responses were respectively used as functional indices of pre- and postsynaptic alpha 2-adrenoceptors in mouse brain. A single injection of various antidepressant drugs had no effect on either response when measured 24 h later. However, 14 days' treatment with sibutramine HCl (3 mg/kg IP), dothiepin (50 mg/kg IP), amitriptyline (10 mg/kg IP), desipramine (10 mg/kg IP) or tranylcypromine (10 mg/kg IP) markedly attenuated both clonidine-induced hypoactivity and mydriasis. Repeated administration of zimeldine (10 mg/kg IP), mianserin (10 mg/kg IP) or clenbuterol (5 mg/kg IP) had no effect on either response. Subchronic treatment with sibutramine HCl (3 mg/kg IP; 3 days) also attenuated pre- and postsynaptic alpha 2-adrenoceptor function. Five ECS (200 V, 2 s) spread over 10 days, but not a single shock, reduced the hypoactivity and mydriasis responses to clonidine. Together, the results indicate that pre- and postsynaptic alpha 2-adrenoceptor function is attenuated by repeated treatment with those antidepressants which acutely increase synaptic levels of noradrenaline. These adrenergic receptor populations are also desensitized by ECS, although this effect is probably mediated via a different mechanism. Finally, the rapid down-regulation observed with sibutramine HCl is not confined to beta-adrenoceptors alone, because pre- and postsynaptic alpha 2-adrenoceptor function is also attenuated by 3 days of treatment with this novel antidepressant drug.
可乐定(0.1毫克/千克腹腔注射)诱导的活动减退和散瞳反应分别用作小鼠脑中突触前和突触后α2-肾上腺素能受体的功能指标。在24小时后测量时,单次注射各种抗抑郁药物对这两种反应均无影响。然而,用盐酸西布曲明(3毫克/千克腹腔注射)、多塞平(50毫克/千克腹腔注射)、阿米替林(10毫克/千克腹腔注射)、地昔帕明(10毫克/千克腹腔注射)或反苯环丙胺(10毫克/千克腹腔注射)治疗14天,可显著减弱可乐定诱导的活动减退和散瞳反应。重复给予齐美利定(10毫克/千克腹腔注射)、米安色林(10毫克/千克腹腔注射)或克伦特罗(5毫克/千克腹腔注射)对这两种反应均无影响。用盐酸西布曲明(3毫克/千克腹腔注射;3天)进行亚慢性治疗也减弱了突触前和突触后α2-肾上腺素能受体功能。在10天内给予5次电休克惊厥(200伏,2秒),而不是单次电击,可降低对可乐定的活动减退和散瞳反应。总之,结果表明,用那些能急性增加去甲肾上腺素突触水平的抗抑郁药物重复治疗可减弱突触前和突触后α2-肾上腺素能受体功能。这些肾上腺素能受体群体也会被电休克惊厥脱敏,尽管这种效应可能是通过不同的机制介导的。最后,盐酸西布曲明观察到的快速下调并不局限于β-肾上腺素能受体,因为用这种新型抗抑郁药物治疗3天也会减弱突触前和突触后α2-肾上腺素能受体功能。